Interplay between viruses and host sumoylation pathways (Q38102561)

28 August 2017

Interplay between viruses and host sumoylation pathways (English)

1 reference

28 August 2017

1 reference

Benjamin G Hale

3

0 references

Chris Boutell

object named as

Chris Boutell

series ordinal

2

0 references

author name string

Roger D Everett

series ordinal

1

1 reference

PubMed ID

23624814

28 August 2017

language of work or name

English

0 references

publication date

29 April 2013

1 reference

Nature Reviews Microbiology

28 August 2017

1 reference

28 August 2017

11

1 reference

28 August 2017

400-411

1 reference

28 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro3015

28 August 2017

0 references

cites work

The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO: a history of modification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Preferential modification of nuclear proteins by a novel ubiquitin-like molecule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMOylation and deSUMOylation at a glance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Human pathogens and the host cell SUMOylation system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Function and regulation of SUMO proteases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Principles of ubiquitin and SUMO modifications in DNA repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PML and PML nuclear bodies: implications in antiviral defence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Interactions between DNA viruses, ND10 and the DNA damage response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Role of promyelocytic leukemia protein in host antiviral defense

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-1 modification of human cytomegalovirus IE1/IE72

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Sumoylation of the major immediate-early IE2 protein of human cytomegalovirus Towne strain is not required for virus growth in cultured human fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Modification with SUMO. A role in transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Modification of nonstructural protein 1 of influenza A virus by SUMO1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

A new protease required for cell-cycle progression in yeast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

DeSUMOylating isopeptidase: a second class of SUMO protease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-1 modification activates the transcriptional response of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Regulation of alphaherpesvirus infections by the ICP0 family of proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

A mechanism for inhibiting the SUMO pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Targeting SUMO E1 to Ubiquitin Ligases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

HPV E6 proteins target Ubc9, the SUMO conjugating enzyme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Intrinsic immunity: a front-line defense against viral attack

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO E3 ligase activity of TRIM proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Functional interactions between ubiquitin E2 enzymes and TRIM proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Nuclear domain 10, the site of DNA virus transcription and replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-interacting motifs of human TRIM5α are important for antiviral activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The cell biology of TRIM5α.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5α.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMOylation of RIG-I positively regulates the type I interferon signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Regulation of IRF2 transcriptional activity by its sumoylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

NF-κB repression by PIAS3 mediated RelA SUMOylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Purification and identification of endogenous polySUMO conjugates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

In vivo localization and identification of SUMOylated proteins in the brain of His6-HA-SUMO1 knock-in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Influenza A virus interacts extensively with the cellular SUMOylation system during infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Will the ubiquitin system furnish as many drug targets as protein kinases?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

The mechanisms of PML-nuclear body formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

An acetylation switch regulates SUMO-dependent protein interaction networks.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Dynamics of component exchange at PML nuclear bodies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

New insights into the role of the subnuclear structure ND10 for viral infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3015

Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments

31 March 2020

1 reference

12 December 2020

PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia

1 reference

12 December 2020

Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption

1 reference

12 December 2020

Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein.

1 reference

12 December 2020

The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO3015

1 reference

PubMed ID

23624814

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23624814